{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:39:45Z","timestamp":1787503185409,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.anai.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:03:47Z","timestamp":1740222227000},"page":"724-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Allergen immunotherapy-induced anaphylaxis"],"prefix":"10.1016","volume":"134","author":[{"given":"Meslina","family":"Almaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Treudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Breiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"K\u00f6hli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pf\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vogelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-1245","authenticated-orcid":false,"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4580","key":"10.1016\/j.anai.2025.02.012_bib0001","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"177","author":"Noon","year":"1911","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anai.2025.02.012_bib0002","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI subcutaneous immunotherapy surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.02.012_bib0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1930.02710270053023","article-title":"So-called anaphylaxis in man","volume":"94","author":"Thommen","year":"1930","journal-title":"JAMA"},{"issue":"4 Pt 1","key":"10.1016\/j.anai.2025.02.012_bib0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0091-6749(92)90129-P","article-title":"Systemic reactions from allergen immunotherapy","volume":"90","author":"Stewart","year":"1992","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2025.02.012_bib0007","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/all.13066","article-title":"European Survey on Adverse Systemic Reactions in AllerGen Immunotherapy (EASSI): a real-life clinical assessment","volume":"72","author":"Calder\u00f3n","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European Survey on Adverse Systemic Reactions in AllerGen Immunotherapy (EASSI): a paediatric assessment","volume":"28","author":"Rodr\u00edguez Del R\u00edo","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.02.012_bib0009","doi-asserted-by":"crossref","first-page":"e12250","DOI":"10.1002\/clt2.12250","article-title":"Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the AllerGen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce","volume":"13","author":"Asllani","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"8009","key":"10.1016\/j.anai.2025.02.012_bib0011","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/pai.13332","article-title":"Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis","volume":"32","author":"Liu","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2025.02.012_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1274241","article-title":"Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2025.02.012_bib0014","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/PPA.S242957","article-title":"Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma","volume":"14","author":"Vogelberg","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1016\/j.anai.2025.02.012_bib0015","doi-asserted-by":"crossref","first-page":"e12245","DOI":"10.1002\/clt2.12245","article-title":"Persistence in allergen immunotherapy: a longitudinal, prescription data-based real-world analysis","volume":"13","author":"Pfaar","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaip.2024.08.036","article-title":"Age- and elicitor-dependent characterization of hymenoptera venom-induced anaphylaxis in children and adolescents","volume":"13","author":"Worm","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2025.02.012_bib0017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2500\/aap.2016.37.3981","article-title":"American Academy of Allergy, Asthma & Immunology membership experience with allergen immunotherapy safety in patients with specific medical conditions","volume":"37","author":"Larenas-Linnemann","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0018","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European Anaphylaxis Registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2025.02.012_bib0019","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/all.14683","article-title":"Peanut-induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry","volume":"76","author":"Maris","year":"2021","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajh.26118","article-title":"Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management","volume":"96","author":"Pardanani","year":"2021","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.02.012_bib0021","first-page":"1","article-title":"The global asthma report 2022","volume":"26","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"issue":"suppl 27","key":"10.1016\/j.anai.2025.02.012_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/pai.13622","article-title":"Safety of allergen-specific immunotherapy in children","volume":"33","author":"De Filippo","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2025.02.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/01455613241257827","article-title":"Exploring side effects of sublingual immunotherapy: a systemic review and meta-analysis","author":"Janz","year":"2024","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anai.2025.02.012_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5414\/ALX02331E","author":"Pfaar","year":"2022","journal-title":"Allergol Select"},{"issue":"1","key":"10.1016\/j.anai.2025.02.012_bib0026","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0027","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2500\/aap.2008.29.3141","article-title":"Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors","volume":"29","author":"Rank","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2025.02.012_bib0028","article-title":"Novel adjuvants in allergen-specific immunotherapy: where do we stand?","volume":"15","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.02.012_bib0029","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1111\/all.15374","article-title":"First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy","volume":"77","author":"Nieto","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0030","article-title":"Safety and adverse reactions in subcutaneous allergen immunotherapy: a review","volume":"94","author":"Incorvaia","year":"2023","journal-title":"Acta Biol Med"},{"issue":"8","key":"10.1016\/j.anai.2025.02.012_bib0031","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1586\/1744666X.2015.1052409","article-title":"Venom immunotherapy: clinical efficacy, safety and contraindications","volume":"11","author":"Kosnik","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.02.012_bib0032","first-page":"211","article-title":"Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study","volume":"47","author":"Asero","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2025.02.012_bib0033","first-page":"726","article-title":"[Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma]","volume":"50","author":"Li","year":"2012","journal-title":"Zhong Hua Er Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.anai.2025.02.012_bib0034","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ACI.0b013e328355b7e4","article-title":"2012 update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis","volume":"12","author":"Simons","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:34:17Z","timestamp":1762364057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1081120625000912"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.02.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergen immunotherapy-induced anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}